Smith Jason Drew sold URGN
July 28, 2025 · Form 4 insider transaction
Smith Jason Drew sold 7,522 shares of UroGen Pharma Ltd. at $19.14 per share, a transaction worth $144.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,522
Price
$19.14
Total value
$144.0K
InsiderSmith Jason Drew
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateJuly 28, 2025
Filing dateJuly 30, 2025
Shares owned after41,492
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold to satisfy withholding tax obligations upon the settlement of performance stock units.